CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson's disease.

Rudy J Castellani, Summer L Nugent, Alan L Morrison, Xiongwei Zhu, Hyoung-Gon Lee, Peggy L R Harris, Vladan Bajić, Hari S Sharma, Shu G Chen, Peter Oettgen, George Perry, Mark A Smith
Author Information
  1. Rudy J Castellani: Department of Pathology, University of Maryland, 22 South Greene Street, Baltimore, MD 21201, USA. rcastellani@som.umaryland.edu

Abstract

CD3ζ is a subunit of the CD3 molecule that, until recently, appeared restricted to T cells and natural killer cells. However, experimental studies have demonstrated a role of CD3ζ in dendritic outgrowth in the visual system as well as in synaptic plasticity. Given the increasing evidence for uncharacteristic recapitulation of neurodevelopmental processes in neurodegenerative diseases, in this study, we evaluated brains from subjects with Parkinson's disease and Lewy body dementia for evidence of aberrant CD3 expression. Our data shows marked CD3ζ in association with the α-synuclein containing pathological lesions, i.e., Lewy bodies and Lewy neurites, in the brains of subjects with Parkinson's disease and Lewy body dementia. This finding raises the novel concept of CD3 dysregulation in these disorders as a pathogenic factor and also furthers the increasing evidence that the recall of aberrant neurodevelopmental processes underlies the pathogenesis of neurodegenerative diseases.

References

  1. Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5710-4 [PMID: 8202552]
  2. Nat Rev Neurosci. 2004 Jul;5(7):521-31 [PMID: 15208694]
  3. Biochim Biophys Acta. 2007 Apr;1772(4):503-8 [PMID: 17223322]
  4. Neurochem Res. 2007 Apr-May;32(4-5):639-44 [PMID: 17006760]
  5. Ann Neurol. 2006 Nov;60(5):617-8; author reply 618-9 [PMID: 16847950]
  6. Nat Immunol. 2001 Jan;2(1):23-7 [PMID: 11135574]
  7. Am J Pathol. 1994 Jul;145(1):42-7 [PMID: 8030754]
  8. Neuron. 2006 Oct 5;52(1):33-8 [PMID: 17015225]
  9. Neuron. 2003 Jul 17;39(2):283-97 [PMID: 12873385]
  10. Nature. 2000 Apr 6;404(6778):567-73 [PMID: 10766232]
  11. Immunity. 2006 Feb;24(2):133-9 [PMID: 16473826]
  12. Neurodegener Dis. 2008;5(3-4):118-21 [PMID: 18322367]
  13. Biochim Biophys Acta. 2007 Apr;1772(4):467-72 [PMID: 17095196]
  14. Am J Pathol. 2009 Mar;174(3):891-7 [PMID: 19164506]
  15. EMBO J. 1993 Nov;12(11):4347-55 [PMID: 8223444]
  16. Nature. 2002 Jul 11;418(6894):177-81 [PMID: 12110889]
  17. Neuron. 2005 Oct 6;48(1):123-37 [PMID: 16202713]
  18. Mol Biol Cell. 2008 Jun;19(6):2444-56 [PMID: 18367546]
  19. Science. 2000 Dec 15;290(5499):2155-9 [PMID: 11118151]
  20. Trends Immunol. 2003 Oct;24(10):554-60 [PMID: 14552840]
  21. Neuropathol Appl Neurobiol. 2008 Aug;34(4):457-65 [PMID: 17995921]
  22. J Biol Chem. 2001 Nov 2;276(44):41120-7 [PMID: 11544251]
  23. J Autoimmun. 2007 Mar-May;28(2-3):59-61 [PMID: 17363216]
  24. J Clin Invest. 2005 Sep;115(9):2508-16 [PMID: 16138193]

Grants

  1. R01 AG028679/NIA NIH HHS
  2. R01 AG028679-02/NIA NIH HHS

MeSH Term

Aged
Aged, 80 and over
Brain
CD3 Complex
Female
Humans
Immunohistochemistry
Lewy Bodies
Lewy Body Disease
Male
Middle Aged
Parkinson Disease
alpha-Synuclein

Chemicals

CD3 Complex
alpha-Synuclein

Word Cloud

Created with Highcharts 10.0.0LewyCD3CD3ζevidenceneurodevelopmentalprocessesParkinson'sdiseasecellsincreasingneurodegenerativediseasesbrainssubjectsbodydementiaaberrantrecallsubunitmoleculerecentlyappearedrestrictedTnaturalkillerHoweverexperimentalstudiesdemonstratedroledendriticoutgrowthvisualsystemwellsynapticplasticityGivenuncharacteristicrecapitulationstudyevaluatedexpressiondatashowsmarkedassociationα-synucleincontainingpathologicallesionsiebodiesneuritesfindingraisesnovelconceptdysregulationdisorderspathogenicfactoralsofurthersunderliespathogenesispathology:abnormalunderlie

Similar Articles

Cited By (8)